Sakai Chemical Industry Co., Ltd.

TSE:4078.T

2557 (JPY) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 82,10583,86180,13584,91887,17789,54187,22383,93885,52086,97386,14179,67379,11387,22181,25785,11598,78192,38084,41083,181
Cost of Revenue 65,37365,38159,09067,69669,01070,89368,33865,45167,38569,92669,99063,67562,06766,36562,58667,82076,48469,01363,24261,400
Gross Profit 16,73218,48021,04517,22218,16718,64818,88518,48718,13517,04716,15115,99817,04620,85618,67117,29522,29723,36721,16821,781
Gross Profit Ratio 0.2040.220.2630.2030.2080.2080.2170.220.2120.1960.1870.2010.2150.2390.230.2030.2260.2530.2510.262
Reseach & Development Expenses 2,7222,6742,3762,4872,8982,9513,2172,9092,7732,6442,5272,89300000000
General & Administrative Expenses 9,19511,89911,25611,02112,15112,1829,0419,09310,74611,00710,82511,50900000000
Selling & Marketing Expenses 1,8722,0372,1601,8972,0002,0601,9361,9331,9231,8751,7691,77200000000
SG&A 11,06713,93613,41612,91814,15114,24210,97711,02612,66912,88212,59413,28100000000
Other Expenses -4037749-42121-5614,194-294-114-431-376-8312931857996-169865-1,644
Operating Expenses 13,78914,07213,55012,91814,15114,24214,19413,93513,51912,88212,59413,28113,00113,56813,34014,24714,66214,50514,56015,096
Operating Income 2,9434,4077,4944,3044,0154,4044,6904,5514,6154,1643,5562,7154,0447,2885,3303,0477,6358,8626,6076,684
Operating Income Ratio 0.0360.0530.0940.0510.0460.0490.0540.0540.0540.0480.0410.0340.0510.0840.0660.0360.0770.0960.0780.08
Total Other Income Expenses Net -6,6465681,728-6,342-18835-1,112-1,073-773-412-1,161-9032,208-1,610-384-477-317-406-150-1,882
Income Before Tax -3,7034,9779,223-2,0373,9995,2393,5783,4783,8433,7532,3951,8136,2535,6784,9472,5717,3188,4566,4584,803
Income Before Tax Ratio -0.0450.0590.115-0.0240.0460.0590.0410.0410.0450.0430.0280.0230.0790.0650.0610.030.0740.0920.0770.058
Income Tax Expense 3,0912,3682,1194221,2711,4611,1921,3231,5171,4691,0047591,9782,2482,3971,3713,1763,3272,5721,923
Net Income -7,0922,3446,747-2,8032,5353,6062,3292,0372,3402,2751,3409684,0343,1442,2169153,7584,7503,4992,677
Net Income Ratio -0.0860.0280.084-0.0330.0290.040.0270.0240.0270.0260.0160.0120.0510.0360.0270.0110.0380.0510.0410.032
EPS -437.64144.81407.06-166.55150.79210.31130.24109.59121.8115.0567.4547.8204.3159.25111.645.6186.4235.6166.6125.3
EPS Diluted -437.64144.81407.06-166.55150.79210.31130.24109.59121.8115.0567.4547.8204.3159.25111.645.6186.4235.6166.6125.3
EBITDA 7,4229,34613,1938,3067,9457,7807,4897,3936,8087,6377,0456,0118,37611,5879,0917,26711,20012,07110,0609,097
EBITDA Ratio 0.090.1110.1650.0980.0910.0870.0860.0880.080.0880.0820.0750.1060.1330.1120.0850.1130.1310.1190.109